1-1 of 1
Martin Cloutier, Bsc
Close
Sort by
Journal Articles

Dose Adjustment and Treatment Interruptions Associated with Second-Line Nilotinib or Dasatinib In Real-World Treatment of Chronic Myeloid Leukemia

Andrew Peng Yu, PhD, Annie Guerin, MSc, Vamsi Bollu, PhD, MBA, Martin Cloutier, Bsc, Denise Williams, MD
Journal: Blood
Blood (2010) 116 (21): 4758.
https://doi.org/10.1182/blood.V116.21.4758.4758
Published: 2010